MANISTEE THERAPEUTICS
MANISTEE THERAPEUTICS
Founded:
2021-01-01
Address:
Concord, Massachusetts, United States
Country:
United States
Status:
Active
Contact:
617-538-7105
Total Funding:
9.5 M USD
Similar Organizations
Fiat Labs
Fiat Labs is currently operating in stealth mode.
Humanoid Labs
Humanoid Labs is currently operating in stealth mode.
Kidas
Kidas analyzes all communications on children's gaming console and alerts parents about potentially dangerous activities in video games.
Linked Store Cayman
Linked Store Cayman is currently operating in stealth mode.
Near Earth Autonomy
Near Earth Autonomy is creating a future where autonomous flight is commonplace and safe.
Twistlock
Twistlock is cloud native cybersecurity for the modern enterprise.
Current Employees Featured
Founder
More informations about "Manistee Therapeutics"
Manistee Therapeutics
Learn About Manistee Now Enrolling: a clinical study for adults with migraine headaches This study is evaluating an investigational drug to see how it works in stopping the symptoms of a …See details»
Manistee Therapeutics 2025 Company Profile: Valuation, Funding ...
When was Manistee Therapeutics founded? Manistee Therapeutics was founded in 2021. Where is Manistee Therapeutics headquartered? Manistee Therapeutics is headquartered in …See details»
Manistee Therapeutics - Crunchbase Company Profile & Funding
9,884 Number of Organizations • $205.6B Total Funding Amount • 23,587 Number of Investors. Track . Private Greater Boston Area Companies (Top 10K) ... When was the last funding …See details»
Manistee Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
May 8, 2025 Explore Manistee Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Neoplasms, Technology Platform:Small …See details»
MANISTEE THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MANISTEE THERAPEUTICS, INC. of Concord, MA. Get the latest business insights from Dun & Bradstreet.See details»
MTX101 in Migraine - Clinical Trials Registry - ICH GCP
Dec 6, 2024 March 26, 2025 updated by: Manistee Therapeutics. A Pilot, Phase 2a, Randomized, Double-blind, Placebo-controlled, Cross-over Clinical Study to Evaluate Safety …See details»
Manistee Therapeutics, inc. · 1188 Centre Street, Newton, MA 02459
Manistee Therapeutics, inc. (Entity #20221269007) is a FPC in Newton, Massachusetts registered with the Colorado Department of State (CDOS). The entity was formed on March 15, 2022 in …See details»
MTX 101 - Manistee Therapeutics - AdisInsight
11 Dec 2024 Manistee Therapeutics plans a phase II trial for Migraine in USA (Sublingual, Tablet) (NCT06728553) ... If your organization has a subscription, there are several access options, …See details»
About - Manistee Therapeutics
About 10 years ago, serendipity made a big wave on the Manistee River by the company founders. A concept for a new pharmaceutical treatment was formed with just the right type of …See details»
FORM D - SEC.gov
Name of Issuer; Manistee Therapeutics, Inc. Street Address 1 Street Address 2; 84 BARNES HILL ROAD: City State/Province/Country ZIP/PostalCode Phone Number of IssuerSee details»
Manistee Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 26, 2021: Venture Round - …See details»
Our Team - Manistee Therapeutics
Janet serves as Head of Clinical Operations for Manistee Therapeutics. She has over 25 years of operational expertise in pharmaceutical and medical device companies, such as Schering …See details»
A Pilot, Phase 2a, Randomized, Double-blind, Placebo-controlled, …
Sponsors Manistee Therapeutics Most Recent Events 26 Mar 2025 Planned End Date changed from 1 Aug 2025 to 1 Jun 2025. 26 Mar 2025 ... If your organization has a subscription, there …See details»
Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment …
The goal of this clinical trial is to learn if drug MTX101 works to treat acute migraine attacks in adults. It will also learn about the safety of the drug MTX101. The main questions it aims to …See details»
Manistee Therapeutics - Contacts, Employees, Board Members, …
Manistee Therapeutics has 1 current employee profile, Founder&Chief Executive Officer, President Robert Bratzler. Robert Bratzler Founder&Chief Executive Officer, President Browse …See details»
Mahan Chehrenama - Manistee Therapeutics | LinkedIn
My story: #Neurologist #Headache&Concussion #Biotech #Research #Strategy #Innovation… · Experience: Manistee Therapeutics · Education: University of Maryland Medical Systems · …See details»
MTX-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
May 8, 2025 BASKING RIDGE, N.J., Aug. 29, 2022 (GLOBE NEWSWIRE) -- MetasTx LLC, a company driven to create novel therapeutics to treat and prevent metastasis of cancers, today …See details»
Janet Vogel - Sr. Clinical Operations Manager - Manistee …
Head of Clinical Operations at Manistee Therapeutics · Experience: Manistee Therapeutics · Education: University of Colorado Boulder · Location: Denver · 500+ connections on LinkedIn. …See details»
Migraine - Manistee Therapeutics
Migraine is a global problem affecting greater than 10% of the population (859 million globally). More than 44 million individuals are affected in the USA. The prevalence peaks in middle life …See details»
Manistee rental market pinched by 525-unit shortfall
14 hours ago MANISTEE — Manistee’s rental market features plenty of unique spaces, but few vacancies for those hoping to call the county home. As of May 20, a quick survey of top rental …See details»